Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Subsequent Events

v3.7.0.1
Note 11 - Subsequent Events
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Subsequent Events [Text Block]
11.
      Subsequent Events
 
On
August 8, 2017,
the Company entered into an exclusive distribution agreement and strategic investment with InControl Medical, LLC (“InControl Medical”), a medical device company that manufactures and distributes devices to treat various incontinence conditions. The agreement grants the Company distribution rights for InControl Medical products to healthcare providers in the United States. The Company will also make a
$2,500,000
equity investment in InControl Medical.